---
title: "SLKovid Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19)"
abbreviation: SLKovid
study_info:
  primary_outcomes: Serum analyses of antibodies against SARS-CoV-2 at 0 (if positive, additionalley at 3, 6 and 12 months) plus questionnaire
  secondary_outcomes: 
    - Characterisation of the immune answer to SARS-CoV-2
    - Comparison of several commercially available CE-certified test Systems
    - Confirmation by neutralisation test
    - Analysis of infection rate by exposition and field of work
    - Evaluation of risk factors and prevention factors
  funding_sources:  Private sponsorship, Institutional budget
recruitment:
  country:
    - Germany
  group: general population
  type: monocenter diagnostic trial
  location:
    - place_name: Heilbronn
      latitude: 49.1427
      longitude: 9.2109
study_numbers:
  study_population: 3000
  population: 125960
study_dates:
  sample_start: 2020-07-01
  sample_end: 2020-12-31
  study_start: 2020-07-01
  study_first_results: 2020-12-31
study_pi:
  name: Uwe Martens
  institution: SLK Kliniken
  role: Professor
  email: dilyana.vladimirova@slk-kliniken.de
team:
  - role: Principal Investigator
    name: Uwe Martens
    position: Head of Department for Haematology, Oncology & Palliative care
    title: Prof. Dr. med.
    institution: SLK Kliniken
  - role: Scientific Officer
    name: Dilyana  Vladimirova
    position: Lead of Scientific Queries
    institution: SLK Kliniken
    title: PhD
---
SARS-CoV-2 antibody test in connection with a short questionnaire (especially regarding field of work, prior tests, prior illness and prior symptoms).